Manisha Vikaskumar Saraf has increased her stake in Callista Industries Ltd through the acquisition of 8,00,000 convertible warrants, raising her diluted shareholding to 6.01%. The warrants were allotted on June 25, 2026, via preferential allotment, as disclosed in a filing submitted to BSE Limited under Regulation 29 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The acquired warrants carry a face value of ₹10 each and are structured to convert into equity shares within 18 months from the date of allotment. The conversion terms specify a 1:1 ratio at a price of ₹10 per share. The instruments do not feature a redemption clause; they will either be converted into equity shares or lapse in accordance with the issue terms.

Prior to this transaction, the acquirer held 10,00,000 warrants, which represented 3.33% of the total diluted share capital. With the addition of the 8,00,000 new warrants, the total holding has risen to 18,00,000 warrants. This new figure accounts for 6.01% of the company's total diluted share capital post-acquisition.

The filing details the capital structure changes resulting from the allotment. The equity share capital of Callista Industries Ltd increased from ₹5,79,65,880 to ₹6,04,65,880 following the transaction. The total diluted share capital, assuming full conversion of outstanding convertible securities, is reported at ₹29,94,65,880.

Manisha Vikaskumar Saraf clarified in the disclosure that she does not belong to the promoter or promoter group of the target company. The shares of Callista Industries Ltd are listed on BSE Limited.

Details of Acquisition

Callista Industries Limited has secured in-principle approval from BSE Limited to raise capital through a preferential issue of convertible warrants and equity shares. The approval allows the company to issue 2,12,50,000 convertible warrants and 56,50,000 equity shares at a price of ₹10 each to the Promoter Group and Non-Promoter Category. This capital infusion is intended to support the company's growth objectives following necessary board and shareholder approvals.

BSE Limited granted the approval via its letter bearing reference number LOD/PREF/PB/FIP/411/2026-27 dated June 19, 2026. The regulatory nod is valid for a period of 15 days from the date of issuance. The company must ensure that the issue and allotment of securities strictly comply with the provisions of the Companies Act, 2013, and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

The exchange has advised the company to strengthen internal controls to monitor trades executed by the proposed allottees. Specifically, Callista Industries must obtain an undertaking from allottees confirming they will not engage in intra-day trading or sell the company's scrip until the allotment date. The responsibility for verifying this compliance and ensuring adherence to Regulation 167(6) of the SEBI ICDR Regulations rests solely with the issuer company.

Following the allotment of securities, the company is required to submit a listing application without delay, along with the applicable fees, in terms of Regulation 14 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Failure to make the listing application within twenty days from the date of allotment may result in penalties as specified in relevant SEBI circulars.

The following table outlines the details of the securities approved for issuance: